• Exchange: London
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharmaceuticals

PXS:LN

0.690 GBp 0.010 1.43%

As of 11:35:04 ET on 04/16/2014.

Snapshot for Provexis PLC (PXS)

Open: 0.680 Day's Range: 0.680 - 0.690 Volume: 2,581,605
Previous Close: 0.700 52wk Range: 0.549 - 2.100 1-Yr Rtn: -10.39%

Stock Chart for PXS

No chart data available.
  • PXS:LN 0.690
  • 1D
  • 1M
  • 1Y
0.700
Interactive PXS Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for PXS

Current P/E Ratio (ttm) -
Estimated P/E(-) -
Relative P/E vs. UKX -
Earnings Per Share (ttm) -0.0024
Est. EPS -
Est. PEG Ratio -
Market Cap (M GBP) 10.73
Shares Outstanding (M) 1,554.82
30 Day Average Volume 2,421,534
Price/Book (mrq) 1.2814
Price/Sale (ttm) 1.8617
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 06/27/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for PXS

  • Revenue
  • Net Income (M/GBP)
  • Profit Margin (%)

Company Profile & Key Executives for PXS

Provexis PLC develops Bioactives for integration into functional foods and beverages. The Company only develops products that have a health benefit which is clearly defined and scientifically proven.

Stephen Nigel MoonChief Executive OfficerIan FordExecutive Director/Secy
More Company Profile & Key Executives for PXS

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil